510(k) DEN180040
DEN180040 is an FDA 510(k) premarket notification submitted by Meridian Bioscience, Inc. for the device "Alethia CMV DNA Amplification Assay, Alethia CMV External Control Kit". The FDA issued a decision of De Novo Granted on November 30, 2018. The device falls under product code QDZ (Qualitative Cytomegalovirus Nucleic Acid-Based Detection Device For Congenital Cytomegalovirus Infection), a Class II device regulated under 21 CFR 866.3181. Meridian Bioscience, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- DENG (De Novo Granted)
- Decision Date
- November 30, 2018
- Date Received
- July 30, 2018
- Clearance Type
- Direct
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Qualitative Cytomegalovirus Nucleic Acid-Based Detection Device For Congenital Cytomegalovirus Infection
- Device Class
- Class II
- Regulation Number
- 866.3181
- Review Panel
- MI
- Submission Type
The device is a qualitative, in vitro diagnostic test for the direct detection of Cytomegalovirus (CMV) DNA in saliva from newborn babies.